RIC-3 activators are a class of chemical compounds that play a significant role in modulating the function of the RIC-3 protein. RIC-3, short for Resistance to Inhibitors of Cholinesterase-3, is a transmembrane protein primarily found in neurons and is involved in the assembly and trafficking of nicotinic acetylcholine receptors (nAChRs). These receptors are essential components of the cholinergic signaling system, which is responsible for transmitting signals between nerve cells and muscle cells at neuromuscular junctions, as well as in various regions of the central and peripheral nervous systems. RIC-3 activators, as the name suggests, are compounds that enhance the activity of RIC-3 in promoting the proper assembly and surface expression of nAChRs.
The precise mechanism of action of RIC-3 activators is still an area of ongoing research, but they are believed to interact with RIC-3 at the molecular level, influencing its conformation and stability. This interaction results in increased efficiency in the formation and translocation of nAChRs to the cell membrane, where they can function as ligand-gated ion channels. By facilitating the proper localization and functionality of nAChRs, RIC-3 activators are integral in regulating cholinergic neurotransmission, which is involved in various physiological processes such as muscle contraction, neuronal communication, and cognitive functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PNU 120596 | 501925-31-1 | sc-203200 sc-203200A | 1 mg 5 mg | $32.00 $84.00 | 1 | |
PNU-120596 is a positive allosteric modulator of the α7 subtype of nAChRs. It enhances channel function by increasing the duration of channel opening. RIC3 promotes the functional expression of α7 nAChRs, and the presence of PNU-120596 may further enhance the activity of these receptors facilitated by RIC3. | ||||||
Galanthamine | 357-70-0 | sc-218556 | 10 mg | $320.00 | ||
Galanthamine is an allosteric potentiating ligand of nAChRs and also serves as an acetylcholinesterase inhibitor. By increasing the concentration of acetylcholine in the synaptic cleft and potentiating receptor response, galantamine can synergize with RIC3 to enhance nAChR activity. | ||||||
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Donepezil is an acetylcholinesterase inhibitor that increases the levels of acetylcholine in the synaptic cleft. This increase can lead to greater activation of nAChRs, whose function and expression at the cell surface are facilitated by RIC3. | ||||||
NS 1738 | 501684-93-1 | sc-204136 sc-204136A | 10 mg 50 mg | $149.00 $620.00 | 1 | |
NS1738 is a positive allosteric modulator of the α7 subtype of nAChRs. By increasing receptor sensitivity to acetylcholine, NS1738 can enhance the action of RIC3 in promoting α7 nAChR function. | ||||||